Prolongation of kidney and skin allograft survival in the rat by monoclonal antibody therapy directed to the RT6.1 T-cell alloantigen.
Fangmann
J
J
Klinik für Abdominal- und Transplantationschirurgie, Medizinische Hochschule, Hannover, Germany.
Schwinzer
R
R
Vogt
P
P
Wonigeit
K
K
D036002:ADP Ribose Transferases; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000945:Antigens, Differentiation, T-Lymphocyte; D006085:Graft Survival; D006239:Haplotypes; D006649:Histocompatibility Antigens / Q000276:immunology*; D007165:Immunosuppression Therapy; D007519:Isoantigens / Q000276:immunology*; D016030:Kidney Transplantation / Q000276:immunology*; D008562:Membrane Glycoproteins; D051381:Rats; D011917:Rats, Inbred Lew; D016038:Skin Transplantation / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D006649:Histocompatibility Antigens; D007519:Isoantigens; D008562:Membrane Glycoproteins; D036002:ADP Ribose Transferases; C090163:Art2b protein, rat